Biora Therapeutics Inc (NAS:BIOR)
$ 0.678 0.02 (3.04%) Market Cap: 24.73 Mil Enterprise Value: 66.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Q2 2023 Biora Therapeutics Inc Earnings Call Transcript

Aug 14, 2023 / 08:30PM GMT
Release Date Price: $3.17 (-8.38%)
Operator

Greetings, and welcome to the Biora Therapeutics's second-quarter 2023 earnings call. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to introduce your host, Chuck Padala, Managing Director with LifeSci Advisors. Thank you. You might begin.

Chuck Padala
LifeSci Advisors - IR

Thank you, operator. Good afternoon, and welcome to the Biora Therapeutics's second quarter 2023 corporate update and financial results conference call. Joining me on the call are Adi Mohanty, Chief Executive Officer; and Eric d'Esparbes, Chief Financial Officer.

Before I turn the call over to Mr. Mohanty, I would like to remind you that today's call will include forward-looking statements within the meaning of the Federal Securities Law, including, but not limited to, the types of statements identified as forward-looking in our quarterly report on Form 10-Q that we filed or will file later today and our subsequent reports with the SEC, which are available on our website in the Investor's section.

These forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot